Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Diabetologia · 2024-07 · 67 (7) · 1168-1180
DOI: 10.1007/s00125-024-06102-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetologia, online erschienen am 20.02.2024. Verfasst von Richard I G Holt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. r.i.g.holt@soton.ac.uk. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 273-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
An association between diabetes and infection has been recognised for many years, with infection being an important cause of death and morbidity in people with diabetes. The COVID-19 pandemic has re-kindled an interest in the complex relationship between diabetes and infection. Some infections occur almost exclusively in people with diabetes, often with high mortality rates without early diagnosis and treatment. However, more commonly, diabetes is a complicating factor in many infections. A reciprocal relationship occurs whereby certain infections and their treatments may also increase the risk of diabetes. People with diabetes have a 1.5- to 4-fold increased risk of infection. The risks are the most pronounced for kidney infection, osteomyelitis and foot infection, but are also increased for pneumonia, influenza, tuberculosis, skin infection and general sepsis. Outcomes from infection are worse in people with diabetes, with the most notable example being a twofold higher rate of death from COVID-19. Hyperglycaemia has deleterious effects on the immune response. Vascular insufficiency and neuropathy, together with altered skin, mucosal and gut microbial colonisation, contribute to the increased risk of infection. Vaccination is important in people with diabetes although the efficacy of certain immunisations may be compromised, particularly in the presence of hyperglycaemia. The principles of treatment largely follow those of the general population with certain notable exceptions. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. r.i.g.holt@soton.ac.uk.
- Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. r.i.g.holt@soton.ac.uk.
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Laboratory for Molecular Epidemiology in Diabetes, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Zitieren
APA
Holt, R. I. G., Cockram, C. S., Ma, R. C. W., & Luk, A. O. Y. (2024). Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia, 67(7), 1168-1180. https://doi.org/10.1007/s00125-024-06102-x
Vancouver
Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67(7):1168-1180. doi:10.1007/s00125-024-06102-x
BibTeX
@article{Holt2024,
author = {Holt, Richard I G and Cockram, Clive S and Ma, Ronald C W and Luk, Andrea O Y},
title = {Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment},
journal = {Diabetologia},
year = {2024},
volume = {67},
number = {7},
pages = {1168--1180},
doi = {10.1007/s00125-024-06102-x}
}
EUVIMED